Search for: "Abbott Laboratories" Results 141 - 160 of 981
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 Nov 2011, 10:18 am by Ray Mullman
Abbott Laboratories, 1:07-cv-00081, U.S. [read post]
1 Mar 2007, 4:22 pm
On February 2, 2007, the Seventh Circuit (Posner, J.) enforced a forum-selection clause favoring Takeda, a Japanese pharmaceutial company, and thus affirmed the District Court's dismissal of Abbott Labs' suit brought in the Northern District of Illinois. [read post]
21 Jan 2014, 4:02 pm by Thaddeus Hoffmeister
  Smithkline was suing Abbott Laboratories for allegedly overpricing its HIV drugs. [read post]
7 Jun 2016, 4:08 am by Myanna Dellinger
In the relevant case,Martina Beverly brought suit against her former employer, Abbott Laboratories, for discrimination and... [read post]
30 Jun 2010, 4:37 am by Legal Profession
The North Carolina Supreme Court held that a trial court did not abuse its discretion when it revoked the pro hac vice status of two attorneys in litigation against Abbott Laboratories and a hospital when a child contracted a rare... [read post]
6 Jun 2011, 2:22 pm by Securites Lawprof
Goetz, a California attorney, with insider trading in the securities of Advanced Medical Optics, Inc. in advance of the January 12, 2009 announcement that Abbott Laboratories, Inc. would acquire Advanced Medical... [read post]
21 Nov 2009, 7:46 am
The Food and Drug Administration has warned Illinois pharmaceutical company Abbott Laboratories over manufacturing violations at its pharmaceutical plant in Illinois. [read post]
16 Jan 2009, 9:55 pm
Abbott to Acquire Advanced Medical Optics On January 12, 2009, Abbott Laboratories and Advanced Medical Optics (AMO) announced an agreement under which Abbott will purchase AMO for about $2.8 billion. [read post]
18 Jan 2008, 1:56 am
Abbott Laboratories (January 18, 2008), the Federal Circuit vacated the lower court's injunction prohibiting future sales of Abbott's genotyping assay kits as an abuse of discretion where the reasonable royalties awarded to Innogenetics included an upfront "market entry fee" based upon future sales by Abbott in a long term market.According to Circuit Judge Moore,Innogenetics conceded at oral argument that the final amount of damages awarded by… [read post]
29 Oct 2010, 6:57 am by Mark Zamora
A class action lawsuit alleging deceptive business practices has been filed against Abbott Laboratories over claims that the pharmaceutical giant sold millions of tubs of infant powder formula that was contaminated with beetles and beetle larvae.The lawsuit, which was brought in federal court in Chicago, was filed on behalf of  a mother of a newborn baby boy. [read post]
19 Aug 2019, 9:47 pm by Patent Docs
("BD"); and (3) Abbott Laboratories and Abbott Molecular, Inc. [read post]
23 Mar 2018, 11:59 am by Sandy
Abbott Laboratories, Inc. can be found here. [read post]
14 May 2011, 1:50 pm
Abbott Laboratories is being sued by children who were born with birth defects, after their pregnant mothers took the epilepsy drug Depakote. [read post]
1 May 2012, 10:25 am by Goldberg & Goldberg
Abbott Laboratories best selling drug, Humira, has been linked to a host of serious side effects, including severe neurological injuries. [read post]
1 May 2012, 5:25 am by Goldberg & Goldberg
Abbott Laboratories best selling drug, Humira, has been linked to a host of serious side effects, including severe neurological injuries. [read post]
24 Sep 2013, 12:42 pm by Thaddeus Hoffmeister
Abbott Laboratories), which is currently before the 9th Circuit Court of Appeals, has raised two interesting questions. [read post]
11 May 2012, 10:00 am by medmalattorney
By Jim Lewis, Nursing Home Abuse Attorney in Virginia Mark Favaloro, an attorney with the Shapiro, Lewis & Appleton law firm, recently wrote about Abbott Laboratories’ guilty plea regarding the illegal marketing of Depakote (divalproex sodium) to nursing homes. [read post]
14 Oct 2010, 9:00 am by Lucas A. Ferrara, Esq.
Abbott Laboratories agrees to withdraw its obesity drug Meridia Abbott Laboratories has agreed to voluntarily withdraw its obesity drug Meridia (sibutramine) from the U.S. market because of clinical trial data indicating an increased risk of heart attack and stroke, the U.S. [read post]
15 May 2012, 8:55 am by staff
Last week, the Department of Justice Announced a record $1.5 Billion settlement with Abbott Laboratories over their mislabeling of the drug Depakote. [read post]